Abstract
Improved photosensitizers (PS), which are the drugs used in Photodynamic Therapy (PDT), a less invasive type of Cancer treatment, have been intensively studied. Most part of PS can aggregate and be deactivated by biomolecules when used in its free form, which compromises the therapeutic efficiency of PDT treatment. Alternatively, PS can be associated with nanoparticles (NPs) aiming the ma…